Fulgent Genetics (FLGT) Change in Accured Expenses (2015 - 2026)

Fulgent Genetics (FLGT) has 12 years of Change in Accured Expenses data on file, last reported at -$2.1 million in Q1 2026.

• Quarterly Change in Accured Expenses rose 71.64% year-over-year to -$2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.3 million (up 302.14% YoY) and the FY2025 annual result came in at $8.9 million, up 324.97% from the prior year.
• Change in Accured Expenses declined to -$2.1 million in Q1 2026 per FLGT's latest filing, from $12.3 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $12.3 million in Q4 2025, with the low at -$13.2 million in Q3 2022.
• Average Change in Accured Expenses over 5 years is -$315882.4, with a median of -$177000.0 recorded in 2023.
• Year-over-year, Change in Accured Expenses slumped 932.2% in 2024 and surged 1862.58% in 2025.
• Fulgent Genetics' Change in Accured Expenses stood at $2.0 million in 2022, then surged by 423.32% to $10.4 million in 2023, then plunged by 93.97% to $628000.0 in 2024, then surged by 1862.58% to $12.3 million in 2025, then plunged by 117.23% to -$2.1 million in 2026.
• Business Quant data shows FLGT's Change in Accured Expenses at -$2.1 million in Q1 2026, $12.3 million in Q4 2025, and -$1.1 million in Q3 2025.